Farrah Fawcett was 62 years old when she died on June 25, 2009, in Santa Monica, California. Born February 2, 1947, she was 62 years and 143 days old at death. Her cause of death was anal carcinoma, a cancer she had been diagnosed with in 2006 and treated for over roughly three years. The age sounds simple, but the number encodes a specific actuarial calculation, a specific disease course, and a set of public misconceptions worth unpacking.

The arithmetic of age at death

Age at death is not a single number. It is a convention, and different conventions give slightly different answers. Fawcett's birth date of February 2, 1947, and death date of June 25, 2009, sit 143 days apart in her final year of life. That means she had completed 62 full years and was partway through her 63rd. Most obituaries and reference sources report completed years, so 62 is the standard figure.

The alternative convention, "age in the 63rd year," is common in some legal and actuarial contexts. It counts the year of life a person is living rather than the years completed. Under that convention she would be described as 62 going on 63, or in her 63rd year. The distinction matters because mortality tables and life-expectancy figures are built on completed years, while some genealogical records use the other convention.

A third wrinkle: time zone and date-of-record. Fawcett died in California, and her death certificate records the local date. No meaningful ambiguity exists here because the death occurred well away from midnight, but in edge cases a death near midnight across time zones can shift the recorded date by one day and therefore the computed age by one day.

Plain language: she had just turned 62 four and a half months before she died.

What actually killed her, mechanistically

Fawcett was diagnosed in 2006 with anal carcinoma, a malignancy arising from the squamous cells lining the anal canal. The mechanism is worth explaining because it corrects a common assumption. Anal cancer is not colorectal cancer. It arises in a different tissue, behaves differently, and is treated differently.

Most anal cancers are linked to high-risk human papillomavirus types, chiefly HPV-16 and HPV-18. The virus inserts its DNA into host cells and produces proteins that disable two key tumor-suppressor pathways, p53 and retinoblastoma protein. When those brakes fail, cells accumulate mutations and proliferate. This is why anal cancer shares a causal root with cervical cancer and why HPV vaccination reduces incidence of both.

The disease typically presents with rectal bleeding, pain, or a palpable mass, symptoms easily attributed to benign conditions like hemorrhoids. That diagnostic overlap is a major reason presentation is often delayed. Fawcett's cancer was reported to have recurred and spread after initial treatment, and she traveled to Germany for experimental therapy in 2009.

Treatment for localized anal cancer is usually chemotherapy plus radiation rather than surgery, because the sphincter-preserving approach avoids permanent colostomy in most patients. That regimen is curative in a large fraction of early-stage cases, but outcomes fall sharply once the tumor has spread to lymph nodes or distant organs.

How 62 compares to the actuarial baseline

At age 62, a US woman in 2009 had a remaining life expectancy of roughly 22 to 23 years, according to period life tables of that era. Fawcett died about 22 years earlier than that baseline. The gap is the useful number, not the raw age.

Anal cancer is uncommon. US incidence is roughly 1 to 2 cases per 100,000 people per year, with about twice the rate in women as in men in the pre-vaccine era. It accounts for a small fraction of all gastrointestinal malignancies. So Fawcett's death from this specific cancer was a low-probability event even though her age at death was not unusual in absolute terms.

Here is the counterintuitive part. A 62nd-year death is not statistically young in the way a death at 35 is. It sits in the zone where chronic and treatable disease becomes the dominant cause. What made Fawcett's death feel premature was not the actuarial math but the visible three-year illness, the public documentation, and the contrast with a highly recognizable youthful public image.

Reference point Age Notes
Fawcett at death 62 years, 143 days Completed years, standard reporting
US female life expectancy at birth, 2009 about 80.6 years Period life table, all causes
US female life expectancy at age 62, 2009 about 22 more years Conditional on surviving to 62
Typical age at anal cancer diagnosis early 60s Median near 60-62 in US data
Five-year relative survival, localized anal cancer roughly 80 percent Stage-dependent, pre-modern-era estimates
Five-year relative survival, distant anal cancer roughly 30 percent Explains the steep drop with spread

Timeline of her illness and public record

The chronology matters because it explains why so many people misremember her age.

Date Event
February 2, 1947 Born in Corpus Christi, Texas
1976 Rises to fame on Charlie's Angels
2006 Diagnosed with anal carcinoma
2007-2008 Undergoes treatment; cancer reported in remission, then recurrence
Early 2009 Travels to Germany for experimental treatment
June 25, 2009 Dies in Santa Monica at age 62
2009 Documentary and public tributes follow; age widely reported as 62

The three-year gap between diagnosis and death is consistent with a cancer that responded initially and then progressed. That pattern, remission followed by recurrence, is common in aggressive solid tumors and is often what patients and families describe as a roller coaster.

The misconceptions that inflate or deflate the number

Several errors recur in thin explainers. One is conflating her age with the age of her most famous character or her peak fame. She was 29 when Charlie's Angels premiered in 1976, so anyone anchored to that image tends to underestimate her age at death.

A second error is mixing up her with other public figures of the same era, which produces off-by-a-few-years answers. A third is treating the reported age as if it were disputed; it is not. Multiple authoritative records converge on 62.

A fourth, subtler error is causal: assuming her death was from a cancer that screening would have caught. Anal cancer has no broadly recommended population screening program comparable to colonoscopy for colorectal cancer. Screening exists in targeted high-risk groups, but there is no universal program. That changes the practical takeaway, discussed next.

Practical steps that follow from the mechanism

The biology points to concrete actions. These are general educational steps, not a personal plan.

Get vaccinated against HPV if you are within the recommended age range. The vaccine prevents the infections that drive most anal cancers, and it is most effective before exposure. Report persistent rectal bleeding, pain, or a new mass to a clinician rather than assuming hemorrhoids, especially if symptoms last more than a few weeks. If you are immunocompromised, including living with HIV, ask about anal cancer screening, since incidence is substantially higher in that group. Know that a normal exam does not rule out malignancy; imaging and biopsy are the definitive steps when suspicion is high. Track your own dates. Knowing your exact age at any given time is trivial, but it is the input to every actuarial and clinical decision that follows.

Limits of what the age tells you

Age at death is a single data point, and it compresses enormous variation. It says nothing about the quality of the final years, the response to treatment, or the accuracy of the underlying diagnosis. It also does not generalize: one celebrity death from a rare cancer is not evidence about population risk.

The survival percentages cited above are era-dependent and stage-dependent, and they shift as treatment improves and as HPV vaccination changes the underlying incidence. Treat them as context, not prognosis. The one robust fact is the arithmetic: 62 years and 143 days, from February 2, 1947, to June 25, 2009.

This article is general educational information about a public figure and about cancer biology. It is not a diagnosis, treatment plan, or substitute for advice from a qualified clinician. If you have symptoms that concern you, contact a local healthcare professional; for immediate danger, use local emergency services.